Nautilus to Participate in the 42nd Annual Cowen Health Care Conference
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate virtually in the 42nd Annual Cowen Health Care Conference on March 7th, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate virtually in the 42nd Annual Cowen Health Care Conference on March 7th, 2022. The presentation is scheduled for 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. Interested parties can access the live and archived webcast through Nautilus’ website.
Headquartered in Seattle, Nautilus is focused on developing a cutting-edge platform for detailed protein analysis, aiming to advance the field of proteomics and its applications in human health and medicine.
Details
News Market Reaction – NAUT
The recorded move for NAUT in the trading session of this news was -4.71%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating virtually in the upcoming 42nd Annual Cowen Health Care Conference.
Nautilus’ management is scheduled to present on Monday, March 7th at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the company’s website at: https://www.nautilus.bio/investors/
About Nautilus Biotechnology, Inc.
Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio
Contacts
Investors:
InvestorRelations@nautilus.bio
Media:
Thermal for Nautilus Biotechnology
Kaustuva Das
Press@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.